Companies · Other
Brooklyn · Other
Diligence memoA one-page analyst read on Q Tonic, LLC — recommendation, valuation, rhythm, risks.→Q Tonic, LLC looks fair against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
Q Tonic, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Q Tonic, LLC is one of 25015 Other companies tracked from Brooklyn. By capital raised it ranks among the largest (ahead of 94% of sector peers), and among the largest by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.
Round size and date are reported; the stage label is inferred from round size (latest is Series B — a $15M–$40M round). Valuation is modeled from stage benchmarks. Directional, not a quoted figure.
Benchmarked against 25015 companies in Other. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 94% of sector peers (real $). Modeled value above 90% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #279 of 371.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| MStar Holding Corp | Series B | $67.6M | $645.8M | 2.16× |
| Chlorum Solutions Llc | Series B | $39.7M | $627.2M | 2.10× |
| IFS Management Holdco, LLC | Series B | $37.5M | $623.8M | 2.09× |
| Benefit Recovery Group, LLC | Series B | $40.0M | $618.4M | 2.07× |
| Shenandoah Growers, Inc. | Series B | $74.2M | $613.4M | 2.05× |
| Zmco Llc | Series B | $40.0M | $610.5M | 2.04× |
| PathStream, Inc. | Series B | $38.8M | $602.3M | 2.01× |
| MXY Holdings, LLC | Series B | $49.9M | $597.0M | 2.00× |
| Ryzac, Inc. | Series B | $42.5M | $594.3M | 1.99× |
| Plouton Datacenter I, Inc. | Series B | $35.3M | $586.5M | 1.96× |
| Es Ei Llc | Series B | $35.3M | $585.7M | 1.96× |
| Factor Law, Inc. | Series B | $36.3M | $570.3M | 1.91× |
| Q Tonic, LLC this company | Series B | $59.2M | $221.8M | 0.74× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Pre-Seed | $450K | 2009-04-15 | $2.5M | $10.4M | 85% |
| Seed | $1.7M | 2012-07-15 | $8.4M | $31.3M | 85% |
| Seed | $1.0M | 2013-10-18 | $5.0M | $18.6M | 85% |
| Seed | $1.0M | 2015-12-29 | $5.2M | $19.4M | 85% |
| Series B | $40.0M | 2019-04-03 | $222.2M | $664.6M | 90% |
| Series B | $15.0M | 2020-12-21 | $83.3M | $221.8M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| George Birman | — | 2 other | 2020-12 |
| Jack Belsito | — | 2 other | 2019-04 |
| Barry Nalebuff | — | 1 other | 2015-12 |
| Jim Goldman | — | 1 other | 2020-12 |
| Barry V. Nalebuff | — | — | 2013-10 |
| Benjamin Karlin | — | — | 2009-04 |
| Benjamin V. Karlin | — | — | 2012-07 |
| Ben Karlin | — | — | 2015-12 |
| Clay Lifflander | — | — | 2015-12 |
| Clay V. Lifflander | — | — | 2013-10 |
| Joe McDonald | — | — | 2019-04 |
| Jordan Silbert | — | — | 2015-12 |
| Jordan V. Silbert | — | — | 2009-04 |
| Timothy V. Tenney | — | — | 2013-10 |
| Tim Tenney | — | — | 2015-12 |
Q Tonic, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| BioIQ, Inc. | Other | Series B | $59.6M | $232.6M | same sector · same stage |
| Discera Inc | Other | Series B | $58.1M | $201.4M | same sector · same stage |
| Eat the Change, Inc. | Other | Series A | $47.1M | $25.1M | network1 shared operator · same sector |
| Systm Foods Inc. | Agtech / Foodtech | Series B | $19.5M | $93.9M | network2 shared operators · same stage |
| Crowdstar Inc. | Other | Series B | $57.2M | $202.0M | same sector · same stage |
| Chromatin, Inc. | Other | Series B | $61.3M | $228.4M | same sector · same stage |
| Machinima Inc | Other | Series B | $65.5M | $207.7M | same sector · same stage |
| FLRish, Inc. | Other | Series B | $52.1M | $242.9M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Botanic Tonics, LLC | Other | Series B | $141.9M | 85% |
| Tonic Group, Inc. | Other Technology | Pre-Seed | $923K | 83% |
| Tonic Development Ltd | Other Technology | Pre-Seed | $17.1M | 81% |
| Qqrgv, Llc | Other | Series A | $178.2M | 81% |
| QMerit, Inc. | Other | Series A | $60.6M | 81% |
| Qualio, Inc. | Other | Series C | $735.5M | 81% |
| QuantAQ, Inc. | Other | Pre-Seed | $5.5M | 81% |
| Ni-Q, LLC | Other | Seed | $68.9M | 81% |
See where Q Tonic, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Q Tonic, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.